Merck, U4133-25MG, URB597

Size:25 mg, Cyclohexylcarbamic acid 3´-carbamoyl-biphenyl-3-yl ester, ≥98% (HPLC), powder
Available Catalog Numbers
Catalog Number: U4133-25MG
Pricing

Send a RFQ.

View RFQ List
Pack Size25 mg
Manufacturer's Pagewww.sigmaaldrich.com/US/en/product/SIGMA/U4133
Description
General description
URB597 binds to active sites of fatty acid amide hydrolases and inhibits their activity. URB597 alters expression of tyrosine hydroxylase and interacts with abnormal-cannabidiol (Abn-CBD) and peroxisome proliferator-activated receptors (PPARs). URB597 elicits antinociception property via cannabinoid receptor by maintaining endocannabinoid anandamide (AEA) levels. URB597 reduces abnormal hyperactivity in neurons and could be for treatment of seizures and improving synaptic plasticity.
Biochem/physiol Actions
Potent, selective fatty acid amide hydrolase (FAAH) inhibitor.
Preparation Note
URB597 is soluble in DMSO at a concentration that is approximately 14 mg/ml.
Specifications

General

UNSPSC Code12352200
PubChem Substance ID329827629
NACRESNA.77
Web Name Suffix Override≥98% (HPLC), fatty acid amide hydrolase (FAAH) inhibitor, powder
MDL numberMFCD05863934
SMILES stringNC(=O)c1cccc(c1)-c2cccc(OC(=O)NC3CCCCC3)c2
InChI keyROFVXGGUISEHAM-UHFFFAOYSA-N
InChI1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24)
descriptionDrug Control: Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet.
assay≥98% (HPLC)
formpowder
drug controlÚj pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet
colorwhite
solubilityDMSO: soluble ~14 mg/mL
storage temp.2-8°C
Quality Level100